Literature DB >> 31985004

Wading Into the Morass: Natural Immunity to Enteropathogens.

Benjamin A Lopman1, Julia M Baker1.   

Abstract

Keywords:  enteropathogen; immunity; mucosa; vaccine

Year:  2020        PMID： 31985004      PMCID： PMC7896272          DOI： 10.1093/infdis/jiaa033

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  24 in total

1.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.

Authors:  Guillermo M Ruiz-Palacios; Irene Pérez-Schael; F Raúl Velázquez; Hector Abate; Thomas Breuer; SueAnn Costa Clemens; Brigitte Cheuvart; Felix Espinoza; Paul Gillard; Bruce L Innis; Yolanda Cervantes; Alexandre C Linhares; Pío López; Mercedes Macías-Parra; Eduardo Ortega-Barría; Vesta Richardson; Doris Maribel Rivera-Medina; Luis Rivera; Belén Salinas; Noris Pavía-Ruz; Jorge Salmerón; Ricardo Rüttimann; Juan Carlos Tinoco; Pilar Rubio; Ernesto Nuñez; M Lourdes Guerrero; Juan Pablo Yarzábal; Silvia Damaso; Nadia Tornieporth; Xavier Sáez-Llorens; Rodrigo F Vergara; Timo Vesikari; Alain Bouckenooghe; Ralf Clemens; Béatrice De Vos; Miguel O'Ryan
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

2.  Negative controls: a tool for detecting confounding and bias in observational studies.

Authors:  Marc Lipsitch; Eric Tchetgen Tchetgen; Ted Cohen
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

3.  Protection from rotavirus reinfection: 2-year prospective study.

Authors:  D I Bernstein; D S Sander; V E Smith; G M Schiff; R L Ward
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

Review 4.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.

Authors:  H Faden; J F Modlin; M L Thoms; A M McBean; M B Ferdon; P L Ogra
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

6.  Acquisition of serum isotype-specific and G type-specific antirotavirus antibodies among children in day care centers.

Authors:  M L O'Ryan; D O Matson; M K Estes; L K Pickering
Journal:  Pediatr Infect Dis J       Date:  1994-10       Impact factor: 2.129

7.  Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.

Authors:  Saranya Sridhar; Alexander Luedtke; Edith Langevin; Ming Zhu; Matthew Bonaparte; Tifany Machabert; Stephen Savarino; Betzana Zambrano; Annick Moureau; Alena Khromava; Zoe Moodie; Ted Westling; Cesar Mascareñas; Carina Frago; Margarita Cortés; Danaya Chansinghakul; Fernando Noriega; Alain Bouckenooghe; Josh Chen; Su-Peing Ng; Peter B Gilbert; Sanjay Gurunathan; Carlos A DiazGranados
Journal:  N Engl J Med       Date:  2018-06-13       Impact factor: 91.245

8.  The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments.

Authors: 
Journal:  Clin Infect Dis       Date:  2014-11-01       Impact factor: 9.079

Review 9.  Protective effects of natural rotavirus infection.

Authors:  F Raúl Velázquez
Journal:  Pediatr Infect Dis J       Date:  2009-03       Impact factor: 2.129

Review 10.  Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human.

Authors:  Louis-Antoine Barel; Laurence A Mulard
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452
View more
  1 in total

1.  Confronting challenges to enterotoxigenic Escherichia coli vaccine development.

Authors:  James M Fleckenstein
Journal:  Front Trop Dis       Date:  2021-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.